|
WO2021064614A1
|
|
Toll-like receptor 7 and/or 8 agonists and uses thereof
|
|
WO2020157694A1
|
|
Antiviral nucleosides and derivatives thereof
|
|
WO2020121123A2
|
|
Cyclopentyl nucleoside analogs as anti-virals
|
|
WO2020121122A1
|
|
Cyclobutyl nucleoside analogs as anti-virals
|
|
TW202035424A
|
|
Macrocyclic flu endonuclease inhibitors
|
|
CN112166191A
|
|
Modified oligonucleotides and methods of use
|
|
US2020270611A1
|
|
Galnac derivatives
|
|
KR20200100033A
|
|
Modified nucleoside phosphoramidite
|
|
KR20190076050A
|
|
Methods for targeting oligonucleotides for HBV CCCDNA
|
|
AU2017326372A1
|
|
Modified oligonucleotides and methods of use
|
|
AU2017311566A1
|
|
Substituted nucleosides, nucleotides and analogs thereof
|
|
EP3426642A1
|
|
Acyclic antivirals
|
|
KR20210028752A
|
|
Antiviral compounds
|
|
MA40032B1
|
|
Substituted nucleosides, nucleotides and analogs thereof for treating viral infections
|
|
USRE48171E
|
|
Substituted nucleosides, nucleotides and analogs thereof
|
